News from the FDA/CDC
News from the FDA/CDC
FDA expands indication for continuous glucose monitoring system
People with diabetes have come a step closer to a life without multiple daily finger sticks, thanks to a recent action by the FDA.
News from the FDA/CDC
FDA bans powdered gloves
The FDA has banned powdered gloves for use in health care settings, citing “numerous risks to patients and health care workers.”
News from the FDA/CDC
XR version of Synjardy gets FDA’s nod
The extended-release version of empagliflozin coupled with metformin in a once-daily tablet has received FDA approval for use in glucose control...
News from the FDA/CDC
FDA affirms bladder cancer warning with diabetes drug
The FDA reaffirmed its warning on the possible risk of bladder cancer associated with use of the type 2 diabetes drug pioglitazone.
News from the FDA/CDC
Empagliflozin first antidiabetes drug to gain cardioprotective indication
Empagliflozin is the first antidiabetes medication to be approved for reducing the risk of cardiovascular death in patients with type 2 diabetes...
News from the FDA/CDC
FDA approves vaginal insert to treat dyspareunia in menopause
It’s the first FDA-approved product containing the active ingredient prasterone, known also as DHEA. It will be marketed by Endoceutics Inc., a...
News from the FDA/CDC
Four of five health care providers get flu shot
Physicians had the highest level of coverage (95.6%), while health care assistants and aides had the lowest (64.5%).